Major Program
Supportive Care and Symptom Management
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
Children's Oncology Group
Status
Completed
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT01503515
This randomized phase III trial studies how well caspofungin acetate works compared to fluconazole or voriconazole in preventing fungal infections in patients following donor stem cell transplant. Caspofungin acetate, fluconazole, and voriconazole may be effective in preventing fungal infections in patients following donor stem cell transplant. It is not yet known whether caspofungin acetate is more effective than fluconazole or voriconazole in preventing fungal infections in patients following donor stem cell transplant.
Intervention
Caspofungin Acetate, Fluconazole, Laboratory Biomarker Analysis, Voriconazole
Condition
Fungal Infection, Hematopoietic and Lymphoid Cell Neoplasm
Investigators
Christopher C Dvorak